Search Results - "Gras Colomer, Elena"
-
1
Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I
Published in Basic & clinical pharmacology & toxicology (01-07-2018)“…The quantification of enzyme activity in the patient treated with enzyme replacement therapy (ERT) has been suggested as a tool for dosage individualization,…”
Get full text
Journal Article -
2
Quantitative assessment of the exposure–efficacy relationship of glucocerebrosidase using Markovian elements in Gaucher patients treated with enzyme replacement therapy
Published in British journal of clinical pharmacology (01-06-2022)“…Aims The aims of this study are (i) to develop a population pharmacokinetic model of enzyme activity in Gaucher‐type 1 (GD1) patients after intravenous…”
Get full text
Journal Article -
3
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Published in Biology (Basel, Switzerland) (23-08-2023)“…Lysosomal storage disorders (LSDs) constitute a large group of rare, multisystemic, inherited disorders of metabolism, characterized by defects in lysosomal…”
Get full text
Journal Article -
4
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis
Published in Pharmaceutics (16-03-2022)“…The treatment of psoriasis has been revolutionized by the emergence of biological therapies. Monoclonal antibodies (mAb) generally have complex pharmacokinetic…”
Get full text
Journal Article -
5
Model-Informed Precision Dosing for Personalized Ustekinumab Treatment in Plaque Psoriasis
Published in Pharmaceutics (04-10-2024)“…Implementing model-informed precision dosing (MIPD) strategies guided by population pharmacokinetic/pharmacodynamic (PK/PD) models could enhance the management…”
Get full text
Journal Article -
6
Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use
Published in European journal of hospital pharmacy. Science and practice (01-11-2019)“…BackgroundIntravenous admixtures of dexketoprofen-trometamol and paracetamol are frequently used in clinical practice due to synergism obtained administering…”
Get full text
Journal Article -
7
Activation and disease control of patients on chronic hemodialysis: An observational study
Published in Nefrología (01-05-2024)“…Patient activation is a concept that refers to the willingness to manage one's health and medical care. To assess it, a patient activation measure (PAM) has…”
Get full text
Journal Article -
8
Activación y control de enfermedad de pacientes en tratamiento crónico con hemodiálisis: un estudio observacional
Published in Nefrología (01-05-2024)“…La activación del paciente es un concepto que se refiere a la voluntad de gestionar su salud y atención médica. Para evaluarla, se ha desarrollado y validado…”
Get full text
Journal Article -
9
Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics
Published in European journal of pharmaceutical sciences (01-07-2022)“…•Supramicellar concentrations of AM enhanced AM absorption.•The contribution of entero-hepatic recirculation of AM has been characterized in rats.•A negligible…”
Get full text
Journal Article -
10
-
11
Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain
Published in Medicina clínica (English ed.) (15-11-2024)“…Patient-reported outcome measures (PROMs) and patient-reported experiences measures (PREMs) are crucial for understanding the impact of GD on quality of life…”
Get full text
Journal Article -
12
-
13
Consensus on the criteria needed for creating a rare-disease patient registry. A Delphi study
Published in Journal of public health (Oxford, England) (01-06-2016)“…Patient registries (PRs) are important tools for public-health surveillance and rare-disease research. The purpose of this study is to identify the most…”
Get full text
Journal Article -
14
Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment
Published in Clinical pharmacokinetics (01-09-2016)“…Background Enzyme replacement therapy (ERT) is currently the standard treatment for patients with Gaucher disease type I (GD1), but the pharmacokinetics have…”
Get full text
Journal Article